David Blecken
Oct 17, 2008

Boehringer Ingelheim selects Vizeum in China

SHANGHAI - German pharmaceutical giant Boehringer Ingelheim has picked Vizeum China to handle media duties for its Mucosolvan cough remedy, following a review that also included incumbent MediaCom and Hakuhodo.

Boehringer Ingelheim selects Vizeum in China
Vizeum will reportedly develop a range of materials and initiatives for the brand, including point-of-sale promotions, advertorials, healthcare booklets, trade communications and community events. The Aegis Group agency restructured as a full-service operation earlier this year.

As the world’s leading expectorant, Mucosolvan positions itself as a remedy that enables mothers to care for their families.

Source:
Campaign China

Follow us

Top news, insights and analysis every weekday

Sign up for Campaign Bulletins

Related Articles

Just Published

Jan 29, 2026

Gemini 3 becomes the default model for AI Overviews

A pair of updates from Google see the tech giant attempt to gain a further foothold in the battle for AI-powered search supremacy.

Jan 29, 2026

Google criticised after blocking measurement ...

YouTube owner sent a 'cease and desist' letter to Barb and Kantar Media.

Jan 29, 2026

Inside Campaign Connect Indonesia: what matters to ...

Candid conversations on growth, AI and the cultural trade-offs of scaling brands, with more than 100 marketers in the room.

Jan 29, 2026

Meta hits $200 billion revenue milestone on ...

Meta reports double‑digit year-on-year revenue growth, with advertising once again accounting for almost all of the top line.